N/A
N=146
Aspiration of Residual Gastric Contents
Infant, Premature · Nutrition, Enteral
Bottom Line
View on ClinicalTrials.gov: NCT01863043 ↗Enrolled (actual)
146
Serious AEs
10.5%
Results posted
Jun 2023
Primary outcome: Primary: Enteral Intake on Day of Life 7 — 27.5; 22.6 mL/kg per day — p=0.27
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- No aspiration of gastric contents (Procedure); Routine aspiration of gastric contents (Procedure)
- Age
- Pediatric
- Sex
- All
- Sponsor
- University of Florida
- Primary completion
- Oct 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Enteral Intake on Day of Life 7 |
27.5; 22.6 | 0.27 |
| PRIMARY Enteral Intake on Day of Life 14 |
83.2; 94.7 | 0.12 |
| PRIMARY Enteral Intake on Day of Life 21 |
109.2; 117.7 | 0.28 |
| PRIMARY Enteral Intake on Day of Life 28 |
119.4; 129.6 | 0.15 |
| PRIMARY Enteral Intake at Day of Life 35 |
123.9; 137.2 | 0.03 sig |
| PRIMARY Enteral Intake on Day of Life 42 |
128.4; 141.6 | 0.03 sig |
| SECONDARY Days to Reach Full Feeds |
18.1; 15.9 | 0.59 |
| SECONDARY Hours Receiving Parenteral Nutrition |
358.8; 356.8 | 0.64 |
| SECONDARY Hours of Central Line Access |
402.6; 398.6 | 0.95 |
| SECONDARY Highest Alkaline Phosphatase Level |
451; 495.5 | 0.95 |
| SECONDARY Occurrence of Cholestasis |
0.040; 0.057 | 0.23 |
| SECONDARY Level of Direct Bilirubin |
0.690; 0.671 | 0.98 |
| SECONDARY Length of Hospital Stay |
86.4; 79.1 | 0.01 sig |
| SECONDARY Episodes of Late Onset Sepsis |
1.38; 0.97 | 0.08 |
| SECONDARY Episodes of Necrotizing Enterocolitis |
0.026; 0.008 | 0.25 |
| SECONDARY Episodes of Ventilator Associated Pneumonia |
0; 0 | — |
| SECONDARY Episodes of Aspiration Pneumonia |
0; 0 | 0.27 |
| SECONDARY Episodes of a Positive Tracheal Culture |
0.055; 0.088 | 0.17 |
| SECONDARY Episodes of 2 or More Positive Tracheal Aspirate Cultures |
0.015; 0.024 | 0.17 |
| SECONDARY Episodes of Bronchopulmonary Dysplasia |
0.512; 0.680 | 0.43 |
| SECONDARY Highest Tracheal Pepsin Level |
1; 0.9 | 0.694 |
| SECONDARY Days of Invasive Ventilation |
14.3; 13.3 | 0.97 |
| SECONDARY Number of Infants Who Died |
6; 1 | 0.60 |
| SECONDARY Number of Abdominal Radiographs |
4.34; 3.81 | 0.25 |
| SECONDARY Episodes of Abdominal Distension |
1.79; 0.590 | 0.001 sig |
| SECONDARY Emesis |
2.46; 5.01 | 0.002 sig |
| SECONDARY Weight |
1129.7; 1145 | 0.03 sig |
| SECONDARY Head Circumference |
25.94; 25.85 | 0.56 |
| SECONDARY Length |
36.41; 36.78 | 0.59 |
| SECONDARY Presence of Blood in Stools |
0.247; 0.254 | 0.888 |
| SECONDARY Level of Fecal Calprotectin |
557.8; 456.1 | 0.694 |
| SECONDARY Serum Gastrin Level |
80.50; 92.29 | 0.248 |
| SECONDARY Serum Motilin Level |
228.5; 225.8 | 0.694 |
| SECONDARY Fecal S100A12 |
195.2; 144.4 | 0.195 |
Summary
The primary purpose of this study is to determine nutrition outcomes and risks to gastrointestinal integrity and function of aspirating for routine gastric contents prior to each feeding in very low birth weight premature infants.
Eligibility Criteria
Inclusion Criteria
- born at 32 weeks of less of gestational age
- birth weight </= to 1250 grams
- receiving some enteral feedings by 72 hours of age
- receiving parenteral feedings by 24 hours of age
Exclusion Criteria
- Congenital or chromosomal abnormalities
- complex congenital heart diseases and congenital anatomic gastrointestinal abnormalities
Data sourced from ClinicalTrials.gov (NCT01863043). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.